1262151-59-6Relevant articles and documents
A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening
Kawaguchi, Mitsuyasu,Okabe, Takayoshi,Terai, Takuya,Hanaoka, Kenjiro,Kojima, Hirotatsu,Minegishi, Izumi,Nagano, Tetsuo
, p. 13479 - 13486 (2011/03/17)
The prevalence of type 2 diabetes is increasing dramatically throughout the world. Recently, dipeptidyl peptidase 4 (DPP4) was identified as a potential antidiabetes target. Many DPP4 inhibitors, such as sitagliptin and vildagliptin, have been developed a